Design Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Arsani William(7.5%),Logos Global Management LP(7.4%), etc.
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director William Arsani
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director George Simeon
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Prasad Deepa
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director William Arsani
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPPE RODNEY W
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berger Heather A.
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berger Heather A.
Design Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Kim Jae B.
Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.3%),Citadel Advisors LLC(3.2%), etc.
Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%), etc.
Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.24%)
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burgess Julie
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jeffries Sean
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPPE RODNEY W
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Ansari Aseem Z.
Design Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.
Design Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPPE RODNEY W
No Data
No Data